TruAlt Bioenergy approves ₹180 Cr guarantee and share pledge for subsidiary's CBG plants
TruAlt Bioenergy approved a ₹180 crore corporate guarantee and pledged 51% shares in its subsidiary, Trualt Gas Private Limited, to secure a NABARD loan for three CBG plants.
While the action enables a new project for the subsidiary, it creates a contingent liability for the parent company through the corporate guarantee and involves pledging shares, representing a notable financial commitment and exposure.
The corporate guarantee and share pledge facilitate a significant expansion project for the subsidiary (setting up three CBG plants), indicating potential future growth and business development in the bioenergy sector.
* TruAlt Bioenergy Limited's Board of Directors, at their meeting on October 28, 2025, approved providing a Corporate Guarantee worth 51% of the project cost to NABARD. * This guarantee is for a term loan facility of ₹180,00,00,000 (Rupees One Hundred Eighty Crore) sanctioned to its subsidiary, Trualt Gas Private Limited (TGPL). * The loan is intended for setting up three Compressed Biogas (CBG) plants, each with a capacity of 20 TPD. * Additionally, the company will pledge its 51% equity shares held in TGPL as security for the said term loan. * The remaining 49% of the guarantee will be secured by the Joint Venture Partner, Sumitomo Corporation, as per the Joint Venture Agreement conditions. * The transaction is considered to be at arm's length, with certain directors of TruAlt Bioenergy also serving on the board of TGPL. * The company states that there is no immediate impact on the listed entity other than disclosure in financial statements, and the pledge does not affect the shareholding pattern of TruAlt Bioenergy Limited.
What to do with a filing like this
TruAlt Bioenergy Limited filed this with the NSE as a statutory disclosure, categorised under other corporate actions. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by TruAlt Bioenergy Limited. Read the original for the full detail.